Ibérica Medtronic has presented in Spain its latest advance in technology applied to diabetes management: a new system of continuous glucose monitoring that will allow diabetes patients to carry out optimal control of their disease.
IPRO2 is a continuous monitoring device that detects those fluctuations in glucose levels that produce complications and normally go unnoticed in glycosylated hemoglobins and in the usual glucose measurements.
Identify the problem facilitates the solution
«IPRO2 is very useful for any patient in which it is considered necessary and help access six -day glycemic profiles.Identified the problem will have to look for a solution.Obviously it is those more complex management patients who can benefit most from IPRO2, ”says Dr. Conget.
In this sense, it is worth highlighting the usefulness of the device in patients with nocturnal hypoglycemia or inadvertent hypoglycemia, patients with difficulties to achieve the objective of HBA1C, pregnant children and women who experience a significant glycemic variability or patients who have discrepancies between HBA1C and notebooksof registration.
Being comfortable access to 288 measurements allows us to know the glycemic profile of the patient in his real and everyday life."Continuously individualized monitoring can help identify periods of the day that require changes in treatment," says the specialist.
Intuitive and useful reports
IPRO2 is simple for both patients and professionals.It includes a glucose sensor and a small data memory that automatically records the information related to glucose.The operation of the device, just 3 x 3 cm, does not require any previous training for the patient.
Once the data has been registered, the information stored on the device is easily downloaded through a fully integrated web platform that allows a simple data evaluation through complete and visual graphics.«The reports are very intuitive and easy to understand with just a look.
Both for the professional and to use them as an educational material for the patient, ”adds Dr. Conget.In this sense, reports are useful to motivate the patient when implementing changes in the management of their disease after checking the effects that exercise guidelines, meals, stress and medication have on their glucose levels.
High degree of satifaction
According to data from a survey conducted in 10 Spanish centers to 117 patients with diabetes who carried IPRO2 for six days, in Spain, 87% assured that the device had allowed them to lead their lives without any restriction, so they would have no problem intake it back.
In the case of professionals, 98% of the participating endocrine said that it would recommend to their patients the periodic use of IPRO2 in the future, as a key tool for improving diabetes control.
From the clinical point of view, in 77% of cases IPRO2 detected at least one hypoglycemia not detected by traditional methods.In 35% of cases, this figure amounted to three previously detected hypoglycemia.
Finally, the professionals participating in the study, belonging to 10 reference hospital centers in Spain and Portugal, said that in 97% of cases the therapy was changed or adjusted based on the IPRO2 reports.
More information: www.medtronic.es />/
I've been looking for something like that, aMeter that was only that, meter and that you could use any device as a receiver, I currently have the Onetouch® Ultrasmart® capillary meter that is compatible with the continuous meter wirelessly.Has anyone tried or knows anything about him?This afternoon I am going to call Medtronic to see how it can be achieved, although I fear that it will be by means of a medical prescription.
All the best.
